Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Subretinal Human Umbilical Tissue-Derived Cell Transplantation Preserves Retinal Synaptic Connectivity and Attenuates Müller Glial Reactivity.

The Journal of neuroscience : the official journal of the Society for Neuroscience | 2018

Human umbilical tissue-derived cells (hUTC or palucorcel) are currently under clinical investigation for the treatment of geographic atrophy, a late stage of macular degeneration, but how hUTC transplantation mediates vision recovery is not fully elucidated. Subretinal administration of hUTC preserves visual function in the Royal College of Surgeons (RCS) rat, a genetic model of retinal degeneration caused by Mertk loss of function. hUTC secrete synaptogenic and neurotrophic factors that improve the health and connectivity of the neural retina. Therefore, we investigated the progression of synapse and photoreceptor loss and whether hUTC treatment preserves photoreceptors and synaptic connectivity in the RCS rats of both sexes. We found that RCS retinas display significant deficits in synaptic development already by postnatal day 21 (P21), before the onset of photoreceptor degeneration. Subretinal transplantation of hUTC at P21 is necessary to rescue visual function in RCS rats, and the therapeutic effect is enhanced with repeated injections. Synaptic development defects occurred concurrently with morphological changes in Müller glia, the major perisynaptic glia in the retina. hUTC transplantation strongly diminished Müller glia reactivity and specifically protected the α2δ-1-containing retinal synapses, which are responsive to thrombospondin family synaptogenic proteins secreted by Müller glia. Müller glial reactivity and reduced synaptogenesis observed in RCS retinas could be recapitulated by CRISPR/Cas9-mediated loss-of-Mertk in Müller glia in wild-type rats. Together, our results show that hUTC transplantation supports the health of retina at least in part by preserving the functions of Müller glial cells, revealing a previously unknown aspect of hUTC transplantation-based therapy.SIGNIFICANCE STATEMENT Despite the promising effects observed in clinical trials and preclinical studies, how subretinal human umbilical tissue-derived cell (hUTC) transplantation mediates vision improvements is not fully known. Using a rat model of retinal degeneration, the RCS rat (lacking Mertk), here we provide evidence that hUTC transplantation protects visual function and health by protecting photoreceptors and preserving retinal synaptic connectivity. Furthermore, we find that loss of Mertk function only in Müller glia is sufficient to impair synaptic development and cause activation of Müller glia. hUTC transplantation strongly attenuates the reactivity of Müller glia in RCS rats. These findings highlight novel cellular and molecular mechanisms within the neural retina, which underlie disease mechanisms and pinpoint Müller glia as a novel cellular target for hUTC transplantation.

Pubmed ID: 29431645 RIS Download

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NEI NIH HHS, United States
    Id: F32 EY027997
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA031833
  • Agency: NIA NIH HHS, United States
    Id: T32 AG000029

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Human Thrombospondin-1 Affinity Purified Polyclonal Ab (antibody)

RRID:AB_2201958

This polyclonal targets Human Thrombospondin-1 Affinity Purified Ab

View all literature mentions

Anti-Gephyrin (antibody)

RRID:AB_2232546

This monoclonal targets Gephyrin

View all literature mentions

Glutamine Synthetase (antibody)

RRID:AB_397879

This monoclonal targets Glutamine Synthetase

View all literature mentions

Anti-CACNA2D1 (CaVα2δ1) (extracellular) Antibody (antibody)

RRID:AB_2039785

This unknown targets CACNA2D1 (CaVα2δ1 Subunit)

View all literature mentions

Anti-Calcium Channel (alpha2/delta-1 Subunit) antibody produced in rabbit (antibody)

RRID:AB_258885

This polyclonal targets Calcium Channel (alpha2/delta-1 Subunit) antibody produced in rabbit

View all literature mentions

Anti-Sox9 (antibody)

RRID:AB_2239761

This polyclonal targets Sox9

View all literature mentions

Bassoon, mAb (SAP7F407) (antibody)

RRID:AB_10618753

This monoclonal targets Bassoon mAb (SAP7F407)

View all literature mentions

Anti-Gephyrin (antibody)

RRID:AB_2232546

This monoclonal targets Gephyrin

View all literature mentions

Human Thrombospondin-1 Affinity Purified Polyclonal Ab (antibody)

RRID:AB_2201958

This polyclonal targets Human Thrombospondin-1 Affinity Purified Ab

View all literature mentions

Glutamine Synthetase (antibody)

RRID:AB_397879

This monoclonal targets Glutamine Synthetase

View all literature mentions

Human Thrombospondin-1 Affinity Purified Polyclonal Ab (antibody)

RRID:AB_2201958

This polyclonal targets Human Thrombospondin-1 Affinity Purified Ab

View all literature mentions